Last update 01 Jul 2024
CD19-CAR-DNT Cells
Last update 01 Jul 2024
Overview
Basic Info
Drug Type Universal CAR-T |
Synonyms RJMty19 |
Target |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators), T lymphocyte replacements |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Related
6
Clinical Trials associated with CD19-CAR-DNT CellsA Phase 1, Open-label, Single Arm Clinical Trial to Evaluate the Tolerability, Safety and Efficacy of RJMty19 in Subjects With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)
A Phase I Clinical Trial of RJMty19 in Treatment of Subjects With Refractory Systemic Lupus Erythematosus
A Clinical Study for the Safety and Efficacy of CD19-CAR-DNT Cells (RJMty19) in the Treatment of Relapsed or Refractory Autoimmune Diseases
100 Clinical Results associated with CD19-CAR-DNT Cells
Login to view more data
100 Translational Medicine associated with CD19-CAR-DNT Cells
Login to view more data
100 Patents (Medical) associated with CD19-CAR-DNT Cells
Login to view more data
100 Deals associated with CD19-CAR-DNT Cells
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-cell lymphoma recurrent | Phase 1 | CN | 30 Apr 2024 | |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Phase 1 | CN | 30 Oct 2023 | |
| Idiopathic Inflammatory Myopathies | Phase 1 | CN | 30 Oct 2023 | |
| Scleroderma, Systemic | Phase 1 | CN | 30 Oct 2023 | |
| Systemic Lupus Erythematosus | Phase 1 | CN | 30 Oct 2023 | |
| B-cell lymphoma refractory | Phase 1 | CN | 15 Jun 2022 | |
| CD19-positive B-cell acute lymphoblastic leukemia | IND Approval | CN | 05 Mar 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
NCT05453669 (NEWS) Manual  | Phase 1 | 12 | (第4剂量组) | alrcdnrxys(ibawmfuvpk) = khqftfthnp xirdmeojly (rodnevznnc ) View more | Positive | 24 Aug 2023 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free